MTOR and cancer: Moreover, these data are consistent with our previous findings that ZY0511 predominately elevates the level of DDIT4 [24], a suppressor of mTORC1 pathway, and inhibits mTOR/P70S6K axis, resulting in cancer cell growth inhibition.